Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Depreciation & Amortization (CF) (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Depreciation & Amortization (CF) for 5 consecutive years, with $14000.0 as the latest value for Q4 2020.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 102.17% to $14000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $54000.0, a 390.91% increase, with the full-year FY2024 number at $39000.0, up 333.33% from a year prior.
  • Depreciation & Amortization (CF) was $14000.0 for Q4 2020 at Forte Biosciences, up from $13000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $224000.0 in Q3 2019 to a low of -$646000.0 in Q4 2019.
  • A 5-year average of $61850.0 and a median of $66500.0 in 2016 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): surged 188.41% in 2018, then tumbled 416.67% in 2019.
  • Forte Biosciences' Depreciation & Amortization (CF) stood at $65000.0 in 2016, then soared by 47.69% to $96000.0 in 2017, then soared by 112.5% to $204000.0 in 2018, then crashed by 416.67% to -$646000.0 in 2019, then surged by 102.17% to $14000.0 in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Depreciation & Amortization (CF) are $14000.0 (Q4 2020), $13000.0 (Q3 2020), and $14000.0 (Q2 2020).